New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
November 20, 2009
09:15 EDTDNDN
theflyonthewall.com: Dendreon January volatility at 59, May at 95 into PDUFA
Dendreon is recently up 50c to $28.55 in pre-open trading. Dendreon's provenge (a drug that prolongs the lives of advanced prostate-cancer patients) has a PDUFA on May 1, 2010, by which time it will respond to Dendreon's amended Biologics License Application (BLA). DNDN January option implied is at 59, February is at 74, May is at 95; verses its 26-week average of 75, according to Track Data, suggesting larger price movement this spring. :theflyonthewall.com



News For DNDN From The Last 14 Days
Check below for free stories on DNDN the last two weeks.
There are 15 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2012
10:30 EDTDNDN
theflyonthewall.com: On The Fly: Analyst Upgrade Summary

Subscribe for More Information :theflyonthewall.com
06:11 EDTDNDN
theflyonthewall.com: Dendreon upgraded to Neutral from Underperform at BofA/Merrill

Subscribe for More Information :theflyonthewall.com

February 1, 2012
13:08 EDTDNDN
theflyonthewall.com: Dendreon CEO change could lead to restructuring, says Cantor
Cantor believes John Johnson's background in marketing and cost structure could lead to a restructuring within Dendreon in 2012. The firm views the CEO transition to Johnson as a good move for Dendreon but keeps a Hold rating on the stock. :theflyonthewall.com
09:27 EDTDNDN
theflyonthewall.com: Pre-market top 5 gainers
The following stocks were the top percentage gainers before the open on solid volume of at least 50,000 shares, trading at over $10. MDVN 19%, STX 14%, WHR 9.2%, FTNT 8.9%, DNDN 5%. :theflyonthewall.com
09:22 EDTDNDN
theflyonthewall.com: Dendreon's new CEO has a history of M&A, says Deutsche Bank
Deutsche Bank said Dendreon's new CEO, John Johnson, has a history of M&A and his fresh perspective might benefit the company's near-term strategy. The firm notes Johnson successfully sold Imclone to Eli Lilly (LLY) and attempted to sell Savient (SVNT). Shares are Buy rated with a $20 price target. :theflyonthewall.com
08:59 EDTDNDN
theflyonthewall.com: Dendreon volatility low as shares rally on succession plan

Subscribe for More Information :theflyonthewall.com
08:17 EDTDNDN
theflyonthewall.com: Dendreon jumps in pre-market trading, resistance at $14.98, then $15.88

Subscribe for More Information :theflyonthewall.com
06:56 EDTDNDN
theflyonthewall.com: Dendreon to host conference call
Conference call to discuss CEO and chairman succession plan will be held on February 1 at 9 am. Webcast Link :theflyonthewall.com
06:35 EDTDNDN
theflyonthewall.com: Dendreon announces CEO and chairman succession plan

Subscribe for More Information :theflyonthewall.com

January 25, 2012
10:29 EDTDNDN
theflyonthewall.com: On The Fly: Analyst Initiation Summary

Subscribe for More Information :theflyonthewall.com
06:53 EDTDNDN
theflyonthewall.com: Stocks with implied volatility movement; DNDN BA
Stocks with implied volatility movement; Dendreon (DNDN), Boeing (BA) according to iVolatility. :theflyonthewall.com

January 24, 2012
16:08 EDTDNDN
theflyonthewall.com: Dendreon initiated with a Hold at Cantor

Subscribe for More Information :theflyonthewall.com
11:44 EDTDNDN
theflyonthewall.com: Dendreon call calls active on renewed takeover chatter

Subscribe for More Information :theflyonthewall.com
11:28 EDTDNDN
theflyonthewall.com: Rumor: Dendreon spikes on renewed takeover chatter "again"

Subscribe for More Information :theflyonthewall.com

January 23, 2012
06:55 EDTDNDN
theflyonthewall.com: Stocks with implied volatility below IV index mean; CCL DNDN

Subscribe for More Information :theflyonthewall.com